Developer docs
API playgroundTry for free, no card

Search company profiles

David Geffen School of Medicine at UCLA

Full company profile

uuid000b1q3

Namestring
David Geffen School of Medicine at UCLA
Legal namestring
David Geffen School of Medicine at UCLA
Company typeenum
Public
Founded yearint
1951
Descriptiontext

The David Geffen School of Medicine at UCLA is an LCME-accredited public medical school founded in 1951 and embedded within UCLA Health, operating with a $3.6B annual budget across 24 departments and 9 research centers and employing a faculty and staff directory of approximately 1,033 members. Its core offerings are educational (four-year MD program, bioscience PhD and postdoctoral training, Graduate Medical Education residencies and fellowships, and continuing professional development), research (translational science via UCLA CTSI, NCI-designated cancer research through the Jonsson Comprehensive Cancer Center, and seven themed research areas spanning cancer, cardiovascular, neuroscience, immunity, metabolism, regenerative medicine, and health equity), and clinical care delivered through UCLA Health's hospital network and four affiliate sites. Revenue is drawn from federal and private research grants, tuition and educational program fees, clinical income routed through the UCLA Health system, and philanthropic donations (including a $31M commitment in late 2025 from Dr. Allen and Charlotte Ginsburg). The institution has built proprietary AI tools — NLP-based AI scribes, a multimodal AI rare disease detector, and the INOVAi Center launched in 2026 for clinical AI evaluation — and maintains unique clinical data assets including the only Familial Mediterranean Fever registry in the Western Hemisphere (700+ patients). Marked recognitions include a 2026 Kavli Prize in Neuroscience to the former dean and multiple elections to the National Academies; the school is also facing a DOJ finding of illegal race-conscious admissions that creates ongoing legal and reputational exposure.

Short descriptiontext

The David Geffen School of Medicine at UCLA is a public, LCME-accredited medical school within UCLA Health that delivers MD and graduate bioscience education, residencies and fellowships, biomedical research across 24 departments, and clinical care via UCLA Health's hospital network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical education, biomedical research, graduate medical training, clinical research, healthcare services
Industry4 codes
1Medical Schools (MD/DO Granting)
CodeEDAHAGABPrimaryYes
2Biomedical Sciences & Medical Research Institutes (University-Based)
CodeEDAHAGAIPrimaryNo
3Academic Medical Centers & Teaching Hospitals (University-Affiliated)
CodeEDAHAGAAPrimaryNo
4Public Research Universities with Academic Medical Centers (AMCs)
CodeEDAHAAACPrimaryNo
NAICS code3 codes
  • Colleges, Universities, and Professional Schools61131
  • General Medical and Surgical Hospitals62211
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-General Medical & Surgical Hospitals, Nec8062
Product category
Medical Education
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Research Grants and Funding
TypeSubscription Recurring
Description

Federal and private research grants supporting biomedical research across multiple themed areas including cancer, cardiovascular, neuroscience, and clinical research

medschool.ucla.edu
2Philanthropic Donations
TypeLicensing Royalties
Description

Major donations supporting biomedical research and education, such as the $31 million commitment from Dr. Allen and Charlotte Ginsburg to UCLA Research Park and the medical school

prnewswire.com
3Tuition and Educational Programs
TypeSubscription Recurring
Description

MD education, graduate programs, residencies, fellowships, and continuing professional development programs

medschool.ucla.edu
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Financial aid and scholarships available for qualifying students
ModelOtherBilling cadenceAnnual
Notes

The school offers financial aid, scholarships, and support programs for medical students through dedicated financial aid offices

medschool.ucla.edu
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

David Geffen School of Medicine at UCLA is an accredited public medical school offering MD education, graduate bioscience PhD programs, medical residencies and fellowships, and continuing professional development. The school also operates 24 academic departments and 9 research centers conducting biomedical and clinical research, and is integrated with UCLA Health to deliver patient care across multiple specialties. The institution recently launched the INOVAi Center to evaluate AI tools in real-world clinical settings.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Prehabilitation programs cut post-operative complications by 48% and reduced hospital stays by 11%
+1 more record
Product overview1 text field

The David Geffen School of Medicine at UCLA is a single unified academic medical institution offering a comprehensive portfolio of medical education, research, and clinical care services. The core offerings include the MD Education Program, Graduate Programs in Bioscience, Medical Residencies & Fellowships, Center for Continuing Professional Development, and Clinical Research Programs. The institution recently launched the INOVAi Center as a new research initiative focused on evaluating AI implementation in healthcare settings.

Product and service8 records
1MD Education Program
CategoryMedical Education
2Graduate Programs in Bioscience
CategoryGraduate Education
3Medical Residencies & Fellowships
CategoryMedical Training
4Center for Continuing Professional Development (CCPD)
CategoryContinuing Medical Education
5Clinical Research Programs
CategoryClinical Research
6INOVAi Center for AI Evaluation in Healthcare
CategoryAI Research
7UCLA Health Clinical Services
CategoryHealthcare Services
8Pre-Med & Pre-Health Opportunities
CategoryPre-Medical Education
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Affiliate medical center providing clinical training and education for residents and fellows, with dedicated associate dean representation at DGSOM

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Affiliate medical center with associate dean representation at DGSOM for collaborative medical education

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Veterans Affairs hospital system providing clinical training opportunities with dedicated associate dean representation

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Affiliate medical center with dedicated associate dean for medical education coordination

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Historically Black medical school partnership with assistant dean for academic affairs representation to promote diversity in medical education

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaboration on home care cooperatives study, co-authored by scholars from Cornell, Weill Cornell Medicine, UCLA, and Kaiser Permanente

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaboration on home care cooperatives studying workforce retention among direct care workers

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NCI-designated comprehensive cancer center integrated with DGSOM for cancer research and treatment

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NIH-funded research infrastructure providing resources for clinical research, research cores, and translational science

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Elite private medical school with similar scope of MD education, biomedical research, and academic medical center operations. Comparable in research output, faculty prestige, and Silicon Valley-adjacent AI/biotech innovation positioning.

TypeDirect peer
Description

Top-ranked research medical school with comparable NIH funding scale, biomedical research output, and academic medical center model. Both are leaders in translating research to clinical care.

TypeDirect peer
Description

Fellow UC system medical school with parallel structure, public university governance, comparable research output, and academic medical center operations. Direct competitor for faculty talent, research grants, and students within the UC system.

TypeDirect peer
Description

Premier medical school with similar breadth of MD education, graduate programs, and biomedical research. Competes directly for top faculty, research funding, and prestigious applicants.

TypeDirect peer
Description

Los Angeles-based private medical school and direct geographic competitor. Competes for the same student pool, faculty, research funding, and clinical training opportunities in the LA market.

TypeDirect peer
Description

Ivy League medical school with comparable research intensity, academic medical center model, and biomedical research portfolio. Competes for NIH funding and top-tier faculty.

TypeDirect peer
Description

Elite medical school with similar MD program, biomedical research portfolio, and academic medical center integration. Competes for research funding and physician-scientist talent.

TypeDirect peer
Description

Private research medical school with comparable scope of medical education, biomedical research, and clinical care. Collaborates with DGSOM on the home care cooperatives research study.

TypeDirect peer
Description

Fellow UC system medical school with parallel structure, comparable biomedical research capabilities, and academic medical center operations. Sister UC school with similar governance and funding models.

TypeDirect peer
Description

Top-tier research medical school with comparable scale of research funding, MD program prestige, and biomedical research output. Competes for faculty recruitment and research grants.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

David Geffen School of Medicine at UCLA

Medical Educationmedschool.ucla.edu

The David Geffen School of Medicine at UCLA is a public, LCME-accredited medical school within UCLA Health that delivers MD and graduate bioscience education, residencies and fellowships, biomedical research across 24 departments, and clinical care via UCLA Health's hospital network.

What David Geffen School of Medicine at UCLA does

The David Geffen School of Medicine at UCLA is an LCME-accredited public medical school founded in 1951 and embedded within UCLA Health, operating with a $3.6B annual budget across 24 departments and 9 research centers and employing a faculty and staff directory of approximately 1,033 members. Its core offerings are educational (four-year MD program, bioscience PhD and postdoctoral training, Graduate Medical Education residencies and fellowships, and continuing professional development), research (translational science via UCLA CTSI, NCI-designated cancer research through the Jonsson Comprehensive Cancer Center, and seven themed research areas spanning cancer, cardiovascular, neuroscience, immunity, metabolism, regenerative medicine, and health equity), and clinical care delivered through UCLA Health's hospital network and four affiliate sites. Revenue is drawn from federal and private research grants, tuition and educational program fees, clinical income routed through the UCLA Health system, and philanthropic donations (including a $31M commitment in late 2025 from Dr. Allen and Charlotte Ginsburg). The institution has built proprietary AI tools — NLP-based AI scribes, a multimodal AI rare disease detector, and the INOVAi Center launched in 2026 for clinical AI evaluation — and maintains unique clinical data assets including the only Familial Mediterranean Fever registry in the Western Hemisphere (700+ patients). Marked recognitions include a 2026 Kavli Prize in Neuroscience to the former dean and multiple elections to the National Academies; the school is also facing a DOJ finding of illegal race-conscious admissions that creates ongoing legal and reputational exposure.

David Geffen School of Medicine at UCLA firmographics

Firmographics
Name
David Geffen School of Medicine at UCLA
Legal name
David Geffen School of Medicine at UCLA
Website
https://medschool.ucla.edu
Company type
Public
Founded year
1951
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
The David Geffen School of Medicine at UCLA is a public, LCME-accredited medical school within UCLA Health that delivers MD and graduate bioscience education, residencies and fellowships, biomedical research across 24 departments, and clinical care via UCLA Health's hospital network.
Ownership category
akta.pro rank

David Geffen School of Medicine at UCLA industry classification

Industry
Product category
Medical Education
NAICS
Colleges, Universities, and Professional Schools (61131), General Medical and Surgical Hospitals (62211), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-General Medical & Surgical Hospitals, Nec (8062)
akta.pro primary industry
Medical Schools (MD/DO Granting) (EDAHAGAB)
akta.pro secondary industries
Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)

Keywords

  • Medical education
  • Biomedical research
  • Graduate medical training
  • Clinical research
  • Healthcare services

Where David Geffen School of Medicine at UCLA is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices1 record

Markets served

David Geffen School of Medicine at UCLA business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Research Grants and Funding: Federal and private research grants supporting biomedical research across multiple themed areas including cancer, cardiovascular, neuroscience, and clinical research
  2. Philanthropic Donations: Major donations supporting biomedical research and education, such as the $31 million commitment from Dr. Allen and Charlotte Ginsburg to UCLA Research Park and the medical school
  3. Tuition and Educational Programs: MD education, graduate programs, residencies, fellowships, and continuing professional development programs

Pricing tiers

ModelBillingPrice
OtherAnnualFinancial aid and scholarships available for qualifying students

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

David Geffen School of Medicine at UCLA product offering

Product offering

Core offering

David Geffen School of Medicine at UCLA is an accredited public medical school offering MD education, graduate bioscience PhD programs, medical residencies and fellowships, and continuing professional development. The school also operates 24 academic departments and 9 research centers conducting biomedical and clinical research, and is integrated with UCLA Health to deliver patient care across multiple specialties. The institution recently launched the INOVAi Center to evaluate AI tools in real-world clinical settings.

Product overview

The David Geffen School of Medicine at UCLA is a single unified academic medical institution offering a comprehensive portfolio of medical education, research, and clinical care services. The core offerings include the MD Education Program, Graduate Programs in Bioscience, Medical Residencies & Fellowships, Center for Continuing Professional Development, and Clinical Research Programs. The institution recently launched the INOVAi Center as a new research initiative focused on evaluating AI implementation in healthcare settings.

Differentiator

Problem solved

Functional benefit

Products and services

  • MD Education Program
  • Graduate Programs in Bioscience
  • Medical Residencies & Fellowships
  • Center for Continuing Professional Development (CCPD)
  • Clinical Research Programs
  • INOVAi Center for AI Evaluation in Healthcare
  • UCLA Health Clinical Services
  • Pre-Med & Pre-Health Opportunities

Quantifiable outcome

  • Prehabilitation programs cut post-operative complications by 48% and reduced hospital stays by 11%
  • +1 more outcomes

Companies that use David Geffen School of Medicine at UCLA

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles4 records

David Geffen School of Medicine at UCLA technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

David Geffen School of Medicine at UCLA partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • Harbor-UCLA Medical CentercoreStrategic or Co-development PartnerAffiliate medical center providing clinical training and education for residents and fellows, with dedicated associate dean representation at DGSOM
  • Cedars-Sinai Medical CentercoreStrategic or Co-development PartnerAffiliate medical center with associate dean representation at DGSOM for collaborative medical education
  • VA Greater Los Angeles Healthcare SystemcoreStrategic or Co-development PartnerVeterans Affairs hospital system providing clinical training opportunities with dedicated associate dean representation
  • Olive View Medical CentercoreStrategic or Co-development PartnerAffiliate medical center with dedicated associate dean for medical education coordination
  • Charles R. Drew University of Medicine & SciencecoreStrategic or Co-development PartnerHistorically Black medical school partnership with assistant dean for academic affairs representation to promote diversity in medical education
  • Cornell ILR SchoolminorStrategic or Co-development PartnerResearch collaboration on home care cooperatives study, co-authored by scholars from Cornell, Weill Cornell Medicine, UCLA, and Kaiser Permanente
  • Kaiser PermanenteminorStrategic or Co-development PartnerResearch collaboration on home care cooperatives studying workforce retention among direct care workers
  • Jonsson Comprehensive Cancer CentercoreStrategic or Co-development PartnerNCI-designated comprehensive cancer center integrated with DGSOM for cancer research and treatment
  • UCLA CTSI (Clinical and Translational Science Institute)coreStrategic or Co-development PartnerNIH-funded research infrastructure providing resources for clinical research, research cores, and translational science

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

David Geffen School of Medicine at UCLA competitors and assessment

Company assessment

Direct peers

  • Stanford University School of Medicine: Elite private medical school with similar scope of MD education, biomedical research, and academic medical center operations. Comparable in research output, faculty prestige, and Silicon Valley-adjacent AI/biotech innovation positioning.
  • Johns Hopkins University School of Medicine: Top-ranked research medical school with comparable NIH funding scale, biomedical research output, and academic medical center model. Both are leaders in translating research to clinical care.
  • UCSF School of Medicine: Fellow UC system medical school with parallel structure, public university governance, comparable research output, and academic medical center operations. Direct competitor for faculty talent, research grants, and students within the UC system.
  • Harvard Medical School: Premier medical school with similar breadth of MD education, graduate programs, and biomedical research. Competes directly for top faculty, research funding, and prestigious applicants.
  • Keck School of Medicine of USC: Los Angeles-based private medical school and direct geographic competitor. Competes for the same student pool, faculty, research funding, and clinical training opportunities in the LA market.
  • Perelman School of Medicine at University of Pennsylvania: Ivy League medical school with comparable research intensity, academic medical center model, and biomedical research portfolio. Competes for NIH funding and top-tier faculty.
  • Columbia University Vagelos College of Physicians and Surgeons: Elite medical school with similar MD program, biomedical research portfolio, and academic medical center integration. Competes for research funding and physician-scientist talent.
  • Weill Cornell Medicine: Private research medical school with comparable scope of medical education, biomedical research, and clinical care. Collaborates with DGSOM on the home care cooperatives research study.
  • UC San Diego School of Medicine: Fellow UC system medical school with parallel structure, comparable biomedical research capabilities, and academic medical center operations. Sister UC school with similar governance and funding models.
  • Duke University School of Medicine: Top-tier research medical school with comparable scale of research funding, MD program prestige, and biomedical research output. Competes for faculty recruitment and research grants.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

David Geffen School of Medicine at UCLA social profiles

Digital presence

David Geffen School of Medicine at UCLA compliance and trust

Trust signal

Compliance1 record

David Geffen School of Medicine at UCLA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

David Geffen School of Medicine at UCLA leadership team

Management profile

Number of profiles

Profiles14 records

David Geffen School of Medicine at UCLA subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

David Geffen School of Medicine at UCLA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

David Geffen School of Medicine at UCLA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about David Geffen School of Medicine at UCLA

What does David Geffen School of Medicine at UCLA do?

David Geffen School of Medicine at UCLA is an accredited public medical school offering MD education, graduate bioscience PhD programs, medical residencies and fellowships, and continuing professional development. The school also operates 24 academic departments and 9 research centers conducting biomedical and clinical research, and is integrated with UCLA Health to deliver patient care across multiple specialties. The institution recently launched the INOVAi Center to evaluate AI tools in real-world clinical settings.

Is David Geffen School of Medicine at UCLA a public or private company?

David Geffen School of Medicine at UCLA is a public company. It is classified as state government owned and is currently operating.

When was David Geffen School of Medicine at UCLA founded?

David Geffen School of Medicine at UCLA was founded in 1951. It employs 5,001 to 10,000 people.

Where is David Geffen School of Medicine at UCLA based?

David Geffen School of Medicine at UCLA is headquartered in Los Angeles, United States, in the North America region.

How does David Geffen School of Medicine at UCLA make money?

Three revenue lines are on record. Research Grants and Funding is the primary driver. The others are philanthropic Donations and tuition and Educational Programs.

Who are David Geffen School of Medicine at UCLA's main competitors?

Direct peers on record are Stanford University School of Medicine, Johns Hopkins University School of Medicine, UCSF School of Medicine, Harvard Medical School, Keck School of Medicine of USC, Perelman School of Medicine at University of Pennsylvania, Columbia University Vagelos College of Physicians and Surgeons, Weill Cornell Medicine, UC San Diego School of Medicine and Duke University School of Medicine.

Does David Geffen School of Medicine at UCLA have an API?

No public API is recorded for David Geffen School of Medicine at UCLA.

What industry is David Geffen School of Medicine at UCLA in?

David Geffen School of Medicine at UCLA's product category is Medical Education. Its primary akta.pro industry code is EDAHAGAB, Medical Schools (MD/DO Granting), with a secondary code of EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based). Its NAICS code is 61131 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
News-MedicalVaginal birth after cesarean more common at Black-serving hospitalsA UCLA-led study of over 1.7 million patients found low-risk patients at predominantly Black-serving hospitals were more likely to attempt and succeed with vaginal birth after cesarean than at hospitals serving few Black patients. Black patients still had lower VBAC success rates overall, but high Black-serving hospitals showed 72% higher likelihood than low-serving facilities.The Straits TimesUS Justice Dept accuses Yale medical school of discriminating against white and Asian applicantsThe US Justice Department on May 14 accused the Yale School of Medicine of violating antidiscrimination laws by using holistic reviews to indirectly determine and favor applicants' race, subverting a 2023 Supreme Court ruling that overturned race-conscious admissions. This marks the second major medical school targeted by the Trump administration in eight days following similar findings against UCLA's David Geffen School of Medicine, with investigations also opened into Stanford, Ohio State, and UC San Diego medical schools. Yale has stated it is confident in its admissions process, while the Justice Department argues the practices demonstrate a willful failure to comply with federal anti-discrimination requirements.ArabnewsUS Justice Department accuses Yale medical school of illegally using race in admissionsThe US Justice Department accused Yale University of illegally considering race in medical school admissions, alleging Black and Hispanic students had higher admission odds despite lower grades and test scores. The letter cited a Black applicant having 29 times higher odds of an interview than an equally strong Asian applicant. The DOJ seeks a voluntary resolution agreement.STATDOJ accuses Yale and UCLA medical schools of discriminating against white and Asian applicantsThe Justice Department sent letters to Yale and UCLA medical schools, alleging illegal discrimination against non-Black and non-Hispanic applicants. The letters cite differences in average MCAT scores and GPAs between racial groups over three admissions cycles. The administration's campaign targets diversity initiatives, and the outcome may pressure the line between medical school and undergraduate admissions.UsnewsUS DOJ Says UCLA's Medical School Favors Black, Hispanic Applicants in AdmissionThe U.S. Justice Department said Wednesday that admissions practices at UCLA's David Geffen School of Medicine were biased in favor of Black and Hispanic applicants, citing findings from a probe as part of the Trump administration's broader crackdown on diversity policies at colleges. The investigation concluded that admitted Black and Hispanic applicants had consistently lower academic qualifications than their white and Asian counterparts, with the DOJ stating the institution violated the law by intentionally discriminating based on race. UCLA's medical school said it was reviewing the report and maintained its admissions process is based on merit and a comprehensive review of each applicant.UsnewsJustice Dept. Finds UCLA Medical School Illegally Used Race in AdmissionsThe Justice Department found that the David Geffen School of Medicine at UCLA illegally considered race in admissions by favoring Black and Hispanic applicants over white and Asian American applicants. A year-long investigation cited data showing admitted Black students in 2024 had an average GPA of 3.72, compared with 3.84 for Asian Americans and 3.83 for white students. The finding sets the stage for either a voluntary resolution to bring UCLA into compliance or potential legal action, including possible loss of federal funding.PR NewswireDr. Allen and Charlotte Ginsburg commit $31 million to UCLA Research Park, David Geffen School of Medicine at UCLAUCLA Health received a $31 million commitment from philanthropists Dr. Allen and Charlotte Ginsburg to advance biomedical research at the UCLA Research Park and the David Geffen School of Medicine at UCLA, bringing their cumulative giving to UCLA to $60 million. The pledge provides $11 million for graduate student support, $10 million for the Biomedical Frontiers Fund to support promising research, and $10 million for research park capital needs including laboratories and equipment. The gift is designed to address the talent bottleneck facing early-career researchers transitioning from training to faculty positions and strengthen UCLA's innovation ecosystem in Los Angeles.PR NewswireFARE Clinical Network Reaches 50 Sites with Continued 2020 Expansion, Offers New Options to Food Allergy CommunityFARE (Food Allergy Research & Education) has expanded its Clinical Network to 50 Centers of Distinction across 23 states and the District of Columbia, adding six new institutions including NorthShore University HealthSystem, University of Illinois at Chicago, UCLA's David Geffen School of Medicine, and the Mayo Clinic/Phoenix Children's Hospital collaborative as new members. Medical claims for emergency treatment of severe food allergy reactions have risen by 377 percent over the past decade, underscoring the growing public health crisis the network aims to address. FARE stated that the new centers will strengthen research collaborations and extend clinical trial participation to additional patient populations.PR NewswireLift Heavier, Run Faster and Get Leaner…With a Sleep Coach?Equinox, in partnership with researchers at the David Geffen School of Medicine at UCLA, unveiled a clinical study linking behavioral sleep coaching to measurable exercise performance improvements, including a 14.1% increase in VO2 Max and a 17.2% decrease in body fat percentage among participants who received sleep coaching versus a control group. The study, conducted over 12 weeks with 32 healthy Equinox members, found that sleep coaching enabled subjects to improve aerobic performance, metabolic threshold, and endurance compared to those who received only athletic training. Timed with the study release, Equinox launched dedicated sleep coaching sessions at 22 club locations across the United States as part of its Tier X Personal Training offering.The DailyElectrical nerve-block research by Case Western Reserve researchers aims at asthma, heart failureCase Western Reserve researchers are developing an electrical nerve-block implant for asthma and heart failure, backed by a $2 million NIH grant. The technology, already used for pain management, aims to block autonomic nerve impulses without surgery or drugs. Collaboration with UCLA and Johns Hopkins will test applications for cardiac failure and asthma.